Lanean...
Pathways to Endocrine Therapy Resistance in Breast Cancer
Breast cancers with positive expression of Estrogen Receptor (ER+) are treated with anti-hormone/endocrine therapy which targets the activity of the receptor, the half-life of the receptor or the availability of estrogen. This has significantly decreased mortality in women with ER+ breast cancer, ho...
Gorde:
| Argitaratua izan da: | Front Endocrinol (Lausanne) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712962/ https://ncbi.nlm.nih.gov/pubmed/31496995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00573 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|